Optimising the impact of COVID-19 vaccination on mortality and hospitalisations using an individual additive risk measuring approach based on a risk adjustment scheme

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • Danny Wende - , Professur für Quantitative Verfahren, insbesondere Ökonometrie, BARMER Institut für Gesundheitssystemforschung (Autor:in)
  • Dagmar Hertle - , BARMER Institut für Gesundheitssystemforschung (Autor:in)
  • Claudia Schulte - , BARMER Institut für Gesundheitssystemforschung (Autor:in)
  • Pedro Ballesteros - , BARMER Institut für Gesundheitssystemforschung (Autor:in)
  • Uwe Repschläger - , BARMER Institut für Gesundheitssystemforschung (Autor:in)

Abstract

In this population-based cohort study, billing data from German statutory health insurance (BARMER, 10% of population) are used to develop a prioritisation model for COVID-19 vaccinations based on cumulative underlying conditions. Using a morbidity-based classification system, prevalence and risks for COVID-19-related hospitalisations, ventilations and deaths are estimated. Trisomies, behavioural and developmental disorders (relative risk: 2.09), dementia and organic psychoorganic syndromes (POS) (2.23) and (metastasised) malignant neoplasms (1.99) were identified as the most important conditions for escalations of COVID-19 infection. Moreover, optimal vaccination priority schedules for participants are established on the basis of individual cumulative escalation risk and are compared to the prioritisation scheme chosen by the German Government. We estimate how many people would have already received a vaccination prior to escalation. Vaccination schedules based on individual cumulative risk are shown to be 85% faster than random schedules in preventing deaths, and as much as 57% faster than the German approach, which was based primarily on age and specific diseases. In terms of hospitalisation avoidance, the individual cumulative risk approach was 51% and 28% faster. On this basis, it is concluded that using individual cumulative risk-based vaccination schedules, healthcare systems can be relieved and escalations more optimally avoided.

Details

OriginalspracheEnglisch
Seiten (von - bis)969-978
Seitenumfang10
FachzeitschriftEuropean Journal of Health Economics
Jahrgang23
Ausgabenummer6
PublikationsstatusVeröffentlicht - Aug. 2022
Peer-Review-StatusJa

Externe IDs

PubMed 34799804

Schlagworte

Ziele für nachhaltige Entwicklung

Schlagwörter

  • Additive risk measuring, COVID-19, Immunization strategy, Risk adjustment scheme, Severe outcomes, Vaccination prioritisation